1. Neuroimaging Biomarkers in Addiction – Hamed Ekhtiari (USA) 2. Current Evidence of fMRI Drug Cue-Reactivity as a Biomarker – Mehran Zare-Bidoky (Iran) 3. Findings from ENIGMA fMRI Drug Cue-Reactivity Database – Anthony Juliano (USA) 4. The Potential of Neuroimaging to Identifying Treatment-Sensitive Neural Biomarkers of Alcohol Use Disorder – Patrick Bach (Germany)
1. Adapting Opioid Use Disorder Treatment During the COVID-19 Pandemic: Innovations, Challenges, and Lessons for the Future – Ali Farhoudian (Iran) 2. Harnessing Technology: Transforming Harm Reduction Services for Greater Impact – Seyed Ramin Radfar (Iran) 3. New Technologies Arising to Reduce Drug-Related Deaths: Lessons Learned from COVID-19 – Alexander Mario Baldacchino (UK) 4. The …
Learned Lessons from COVID-19 in Substance Use Treatment Read More »
1. Overview of Singapore’s Drug Situation and Policies – Cheng Lee (Singapore) 2. Addictions in Youths: Trends & Practical Tips for Parents – Lambert Low (Singapore) 3. Counselling Approaches for Addressing Youth Addictions in Singapore – Jamie Susie Thomas (Singapore)
Integrated Treatment for Opiate and Stimulant Use Disorders: An ISAM/ASAM/NIDA Symposium – Gregory Bunt, Stephen Taylor, Marc Potenza, Kathleen Brady (USA)
1. Treatment Effectiveness, Retention and Abstinence in Female Opioid Users on OAT: A Review of Literature – Piyali Mandal (India) 2. Trends in the Use of OAT in Female Opioid Users at National Drug Dependence Treatment Centre, India: 2015-2023 – Hemant Choudhary (India) 3. Barriers to Bridges: Policy and Guideline Reforms for Females Seeking OAT …
Bridging the Gender Gap: Effective Opioid Agonist Treatment for Women Read More »
Cannabis/Cannabinoids for Clinical Management of Pain – Jag Khalsa (USA), Marc Potenza (USA), Gregory Bunt (USA), Ahmed Yousif Ali (UAE)
1. Trajectories of Cannabis-Induced Psychosis and First-Episode Psychosis with Cannabis Use Disorder – Nationwide Cohort Study – Antti Mustonen (Finland, Sweden) 2. Prognosis and Pharmacological Treatment of Amphetamine-Induced Psychosis – Heidi Taipale (Finland, Sweden) 3. The Impact of Cannabis Use Disorder on Bipolar Disorder Trajectories – Lisa Lappalainen (Finland)
1. Neurobiological cue reactivity – focus in diagnostics and therapy – Anne Beck (Germany) 2. Effective connectivity in corticostriatal networks associated with craving – Antonio Verdejo-Garcia (Australia) 3. Move by move towards abstinence: chess-based cognitive remediation training to improve cognitive function and treatment outcome in substance use disorders – Sabine Vollstädt-Klein (Germany)
1. Patient Routes of People with Alcohol Use Disorders in Germany (PRAGMA): A data linkage study – Bernd Schulte (Germany) 2. Severity of alcohol use disorder in electronic health records – Jakob Manthey (Germany) 3. Guideline-compliant care: Differences in hospitalization rates in people with and without post-acute treatment after qualified withdrawal – Ludwig Kraus (Germany) …
1. Innovative Treatment Development for Gambling Disorder – Marc Potenza (USA) 2. Rewiring Reward Pathways: Exploring rTMS as a Novel Approach for Gambling Disorder in Indonesia – Kristiana Siste (Indonesia) 3. Blended CBT and mindfulness for Addictive behaviors – Sophia Achab (Switzerland)
